Abstract:Abstract The purpose of the present study is to examine the current situation of sedative-related disorders (mainly benzodiazepines) in Japan and the clinical characteristics of Japanese patients with this disorder. Subjects were 671 drug-related disorder patients diagnosed according to the ICD-10 classification as “F1: mental and behavioural disorders due to psychoactive substance use,” who abused psychoactive substances other than alcohol. Of all the psychiatric hospitals in Japan between September and October 2010, these drug-related disorder patients had consecutively consulted or were admitted to 153 psychiatric hospitals. The present study was conducted by means of a mail survey. Subjects’ clinical information, including history of psychoactive substance use, means of access to the primary drug of abuse, other ICD-10 diagnoses including F1 subcategory and comorbid psychiatric disorders, and recent history of self-destructive behavior, were collected from the attending psychiatrists of each subject. The data thus gathered concerning sedative-related disorder patients were compared with those patients with methamphetamine-related disorder, which has been the most serious drug-related problem in Japan since the 1950s. Out of the 671 subjects, 119 patients mainly abusing sedatives (the SRD group) were identified, while 361 patients were identified as mainly abusing methamphetamine (the MRD group). The MRD group was the largest population (53.8% of the total subjects), followed by the SRD group (17.7%), the inhalant-related disorder group with 56 patients (8.3%), and so on. Compared with the MRD group, the SRD group was younger, contained more female patients, and had a lower incidence of history of involvement with anti-social societies and anti-social behavior. Patients of the SRD group were more likely to have started abusing drugs with the intention of reducing the unpleasant symptoms of insomnia (42.9%), anxiety (26.1%), and depression (16.0%), and to acquire the drugs they abused from medical institutions such as psychiatric or primary care clinics (82.1%), while patients of the MRD group were more likely to have started out of curiosity (35.1%) or in response to peer pressure (47.1%), and to acquire their drugs from a “pusher” (32.8%). Additionally, in the SRD group, the ICD-10 F1 subcategory diagnoses that were clinically most important were “dependence syndrome” (64.0%), “harmful use” (16.2%) and “acute intoxication” (16.2%), while the most important subcategory diagnosis in the MRD group was “psychotic disorder” (34.3%) and “residual disorder and late-onset psychotic disorder” (32.9%). Further, comorbid psychiatric disorders were more frequently found in the SRD group than in the MRD group; notably, co-occurrence of mood disorder was found in 45.0% of the SRD group in contrast to the MRD group (11.9%). Recent episodes of deliberate self-harm behavior were also more frequently found in the SRD group than the MRD group (33.6% vs. 10.5%); the major means by which these patients harmed themselves was by overdosing on prescribed drugs (23.5% vs. 4.7%). The present study suggests that sedative-related disorder is an important clinical issue in the field of drugrelated disorders in Japan today, and that SRD patients may represent a distinct type of drug abusers whose clinical characteristics are different from those of MRD patients. The development and spread of treatment programs for “dependence syndrome” and “harmful use” will help SRD patients, and educating psychiatrists about SRD will help prevent future sedative abuse.

The effect of education regarding treatment guidelines for schizophrenia and major depressive disorders on psychiatrists' hypnotic medication prescribing behavior: a multicenter study

Characteristics of the treatments for each severity of major depressive disorder: A real-world multi-site study

Attitudes Toward Taking Medication among Outpatients with Schizophrenia: Cross-National Comparison Between Tokyo and Beijing

Treatment strategies for insomnia in Japanese primary care physicians' practice: A Web-based questionnaire survey

International study on antidepressant prescription pattern at 20 teaching hospitals and major psychiatric institutions in East Asia: Analysis of 1898 cases from China, Japan, Korea, Singapore and Taiwan

Factors associated with hypnotics polypharmacy in the Japanese population

0386 Brief cognitive-behavioral therapy for insomnia among Japanese university students with sleep disturbances

0424 Evaluating Sedative-Hypnotics Education Across Diverse Communities Using Community Alignment Theory

Sleep Awareness of Japanese Outpatients: A Survey at a Psychiatry Department of a University Hospital

Antipsychotic Medications in Major Depression and the Association with Treatment Satisfaction and Quality of Life: Findings of Three National Surveys on Use of Psychotropics in China Between 2002 and 2012

Influence of Dementia-Specialized Care Team on Clinical Outcomes in a General Hospital

The Feasibility and Efficacy of Social Cognition and Interaction Training for Outpatients With Schizophrenia in Japan: A Multicenter Randomized Clinical Trial

Current Situation and Clinical Characteristics of Sedative-Related Disorder Patients in Japan: Comparison with Methamphetamine-Related Disorder Patients

Randomized Controlled Trial on the Effects of a Combined Sleep Hygiene Education and Behavioral Approach Program on Sleep Quality in Workers with Insomnia

Sleep education with self-help treatment and sleep health promotion for mental and physical wellness in Japan

Association between the course of hypnotics treatment for insomnia and work functioning impairment in Japanese workers

Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: Focus on antipsychotics

Psychiatrist characteristics related to patient outcome in Japan

Practice Guidelines for Bipolar Disorder by the JSMD (Japanese Society of Mood Disorders)

1097 Education Intervention Improves Sedative Use for Healthy Sleep & Insomnia Management

Changes in psychopharmacotherapy for patients with schizophrenia in a psychiatric institution in Japan: A 12-year prescription survey pre- and post-introduction of clozapine